Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-06-11
1996-12-31
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 14, 514 15, 514 16, 514 17, 514 18, 530326, 530327, 530328, 530329, 530330, 530331, A61K 3800, A61K 3804, C07K 500, C07K 700
Patent
active
055894585
ABSTRACT:
Compounds which display a surface similar to the surface presented by one of five distinct lateral domains of CD4 are disclosed. Methods of treating individuals suspected of suffering from or susceptible to conditions characterized by an undesired immune response comprising administering to the individual at least one compound which mimics a portion of the lateral surface of the CD4 glycoprotein are disclosed.
REFERENCES:
Carr et al., J. Biol. Chem., vol. 264, No. 35, issued 15 Dec. 1989, pp. 21286-21295.
Harris et al., Eur. J. Bioch., vol. 194, pp. 611-620, 1990.
Bank and Chess, Perturbation Of The T4 Molecule Transmits A Negative Signal To T Cells, J. Exp. Med. 1985, 162, 1294-1303.
Barber et al., The CD4 and CD8 Antigens Are Coupled To A Protein-Tyrosine Kinase (p.sup.56lck) That Phosphorylates The CD3 Complex.
Biddison et al., Possible Involvement Of The OKT4 Molecule In T Cell Recognition Of Class II HLA Antigens, J. Exp. Med. 1982, 156, 1065-1071.
Dianzani et al., Molecular Associations On The T Cell Surface Correlate With Immunological Memory, Eur. J. Immunology 1990, 20, 2249-2257.
Fleury et al., Mutational Analysis Of The Interaction Between CD4 and Class II MHC: Class II Antigens Contact CD4 On A Surface Opposite The gp120-Binding Site, Cell 1991, 66, 1037-1049.
Gay et al., Functional Interaction Between Human T-cell Protein CD4 And The Major Histocompatibility Complex HLA-DR Antigen, Nature 1987, 328, 626-629.
Glaichenhaus et al., Requirement For Association Of p56.sup.lck with CD4 In antigen-Specific Signal Transduction In T Cells, Cell 1991, 64, 511-520.
Jameson, B. A., Modelling In Peptide Design, Nature 1989, 341, 465.
Janeway, Charles A., The Co-Receptor Function of CD4, Sem. Immunology 1991, 3, 153-160.
Janeway et al., Cross-Linking And Conformational Change In T-Cell Receptors: Role In Activation And In Repertoire Selection, CSH Symp. Quant. Biol. 1989, LIV, 657-666.
Kumar et al., A Two-Dimensional Nuclear Overhauser Enhancement (2D NOE) Experiment For The Elucidation Of Complete Proton Cross-Relaxation Networks In Biological Macromolecules, Biochem. Biophys. Res. Commun., 1980, 95, 1.
Ledbetter et al., Signal Transduction Through CD4 Receptors: Stimulatory vs. Inhibitory Activity Is Regulated By CD4 Proximity To The CD3/T Cell Receptor, Eur. J. Immunology 1988, 18, 525-532.
Matsui, et al., Low Affinity Interaction Of Peptide-MHC Complexes With T Cell Receptors, Science 1991, 254, 1788-1791.
McDonnell et al., Direct Invovement Of the CDR3-Like Domain Of CD4 In Helper Cell Activation, J. Immunol. 1992, 149, 1626.
Mittler et al., T-Cell Receptor-CD4 Physical Association In A Murine T-Cell Hybridoma: Induction By Antigen Receptor Ligation, PNAS USA 1989, 86, 8531-8535.
Mittler et al., Physical Associations Between CD45 and CD4 or CD8 Occur As Late Activation Events In Antigen Receptor-Stimulated Human T Cells, J. Immunology 1991, 147, 3434-3440.
Mustelin et al., Rapid Activation Of The T-Cell Tyrosine Protein Kinase pp56.sup.lck By The CD45 Phosphotyrosine Phosphatase, PNAS USA 1989, 86, 6302-6306.
Ostergaard and Trowbridge, Coclustering CD45 With CD4 Or CD8 Alters The Phosphorylation And Kinase Activity Of p56.sup.lck, J. Exp. Med. 1990, 172, 347-350.
Parnes, "Molecular Biology and Function of CD4 and CD8," Adv. Immunology, 44:265-311, 1989.
Matthews et al., "Studies on the Leukocyte-Common Antigen: Structure, Function, and Evolutionary Conservation," CSH Symp. Quant. Biol., LIV, 675-682, 1989.
Rivas et al., "CD4 Molecules are Associated with the Antigen Receptor Complex on Activated But Not Resting T Cells," J. of Immunology, 140:2912-2918, 1988.
Shaw et al., "Short Related Sequences In the Cytoplasmic Domains of CD4 and CD8 Mediate Binding To the Amino-Terminal Domain of the p56.sup.ck Tyrosine Protein Kinase," Molec. Cell. Biol., 10:1853-1862, 1990.
Tite et al., "The role of L3T4 in T Cell Activation: L3T4 May be Both An Ia-Binding Protein and A Receptor That Transduces A Negative Signal," J. Mol. Cell. Immunol., 2:179-189, 1986.
Turner et al., "Interaction of the Unique N-Terminal Region of Tyrosine Kinase p56.sup.lck with Cytoplasmic Domains of CD4 and CD8 is Mediated by Cysteine Motifs," Cell, 60:755-765, 1990.
Maddon et al., "The Isolation and Nucleotide Sequence of a cDNA Encoding the T Cell Surface Protein T4: A New Member of the Immunoglobulin Gene Family," Cell, 42:93-104, 1985.
Maddon et al., "The T4 Gene Encodes the AIDS Virus Receptor and Is Expressed in the Immune System and the brain," Cell, 47:333-348, 1986.
Hussey et al., "A soluble CD4 protein selectively inhibits HIV replication and syncytium formation," Nature, 331:78-81, 1988.
Merrifield, R. B., "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide," J. Am. Chem. Soc., 85:2149-2154, 1963.
Jameson et al., "Location and Chemical Synthesis of a Binding Site for HIV-1 on the CD4 Protein," Science, 240:1335-1339, 1988.
Raine et al., "On the immunopathology of plaque development and repair in multiple sclerosis," J. of Neuroimmunology, 20:189-201, 1988.
Korngold et al., "Acute Experimental Allergic Encephalomyelitis in Radiation Bone Marrow Chimeras Between High and Low Susceptible Strains of Mice," Immunogens, 24:309-315, 1986.
Korngold and Sprent, "Variable Capacity of L3T4.sup.+ T Cells To Cause Lethal Graft-Versus-Host Disease Across Minor Histocompatibility Barriers in Mice," J. Exp. Med., 165:1552-1564, 1987.
Jameson Bradford A.
Korngold Robert
McDonnell James M.
Davenport Avis M.
Thomas Jefferson University
LandOfFree
Compounds that inhibit T cell proliferation and methods for usin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that inhibit T cell proliferation and methods for usin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that inhibit T cell proliferation and methods for usin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142138